The companies entered bankruptcy about six months after VitalSpring CEO Sreedhar Potarazu, MD, pleaded guilty to $32 million in shareholder fraud and $7.5 million in employment tax fraud.
VitalSpring and Enziime said in their bankruptcy petitions they have estimated combined liabilities of $65 million, which the companies owe to more than 350 creditors. The creditors, including several physicians and investment groups, are investors in the companies. The companies reported less than $50,000 in combined assets, according to the report.
More articles on healthcare finance:
Austin hospital closes after 133 years; relocates services
13 healthcare bankruptcies so far in 2017
CMS further delays major bundled payment initiatives: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
